Pieter Jan Vos | CEO
VirXcel B.V.

Pieter Jan Vos is an experienced biotechnology and life-sciences entrepreneur with expertise in company building, financing, licensing, partnership development and multidisciplinary R&D management. Through Amspar B.V., active in pharmaceutical licensing with a primary focus on generic pharmaceuticals, he established approximately 30 licensing agreements across five continents. He is also co-founder and former CEO of MyLife Technologies, a University of Twente spin-off previously based at Leiden Bio Science Park. At MyLife Technologies, he raised dilutive and non-dilutive financing and supported advancement of its microneedle technology for vaccine delivery into clinical studies. The technology is presently further being developed by CeraVx. Pieter Jan is co-founder and CEO of VirXcel since 2024.